ArticleBMC cardiovascular disorders2023

HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins.

Jiawen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.